Invention Publication
- Patent Title: SPIROCYCLIC INHIBITORS OF HEPATITIS B VIRUS
-
Application No.: US17798784Application Date: 2021-02-09
-
Publication No.: US20230151027A1Publication Date: 2023-05-18
- Inventor: Romano DI FABIO , Vincenzo SUMMA , Leda Ivanova BENCHEVA , Raffaele DE FRANCESCO , Lorena DONNICI , Luca GUIDOTTI , Matteo IANNACONE , Adolfo PRANDI , Marilenia DE MATTEO , Pietro RANDAZZO
- Applicant: Ospedale San Raffaele S.r.l. , Istituto Nazionale Genetica Molecolare - INGM
- Applicant Address: IT Milano (MI)
- Assignee: Ospedale San Raffaele S.r.l.,Istituto Nazionale Genetica Molecolare - INGM
- Current Assignee: Ospedale San Raffaele S.r.l.,Istituto Nazionale Genetica Molecolare - INGM
- Current Assignee Address: IT Milano (MI); IT Milano (MI)
- Priority: WO 156716.1 2020.02.11 WO 201798.4 2020.10.14
- International Application: PCT/EP2021/053099 2021.02.09
- Date entered country: 2022-08-10
- Main IPC: C07D515/14
- IPC: C07D515/14
Abstract:
The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating, preventing or curing HBV infection and related conditions. The present invention also relates to pharmaceutical compositions containing the compounds.
Information query
